Clinical Trials Directory

Trials / Unknown

UnknownNCT04327492

Hemathologic and Imagiologic Predictors of Stroke During Carotid Endarterectomy With Regional Anesthesia

Clinical, Hematological, and Imagiologic Predictors of Postoperative Complications and Long Term Cardiovascular Events After Carotid Endarterectomy With Regional Anesthesia

Status
Unknown
Phase
Study type
Observational
Enrollment
272 (estimated)
Sponsor
Universidade do Porto · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers

Summary

Establish and validate biomarkers which improve the predictive value of current risk stratification models for patients benefiting from carotid revascularization, outperform existing biomarkers, and reach clinical application standards.

Detailed description

The authors hypothesize FGF-23 and GDF-15 could predict cerebral ischemia, postoperative complications and long term major cardiovascular events, particularly in patients developing symptomatic neurologic ischemia after circulation shutdown. Establish and validate biomarkers which improve the predictive value of current risk stratification models for patients benefiting from carotid revascularization, outperform existing biomarkers, and reach clinical application standards. Clarify the pathophysiology of carotid endarterectomy-related stroke and the role of GDF-15, FGF-23, BNP and hs-troponin I and other biomarkers in the prognosis of symptomatic carotid stenosis. Imagiologic markers are to be included - intima-media; gray weale plaque classification, cerebral CT Peak wave velocity

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBiomarker - FGF 23; troponin I; PCR - high sensitivity; BNPpeak wave velocity; gray weale plaque classification

Timeline

Start date
2020-04-01
Primary completion
2021-12-31
Completion
2022-12-31
First posted
2020-03-31
Last updated
2020-03-31

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT04327492. Inclusion in this directory is not an endorsement.